ITGA2 is enriched in glioma stem-like cells to promote invasion by modulating PD-L1 and activating STAT3 phosphorylation, enhancing epithelial-mesenchymal transition [[24], [25], [26]]. This evidence concerns the gene STAT3 and central nervous system cancer.